Reported value$200K12,700 shares at $15.73
For this personNormal for them2 buys · 0 sales on file
Similar buys beat S&P40%152 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
Reasons for caution
- Other insiders sold $481K in the same 90 days, more than was bought.
- Small next to what they already own (holding up 1.3%).
- Similar past buys beat the S&P 500 only 40% of the time (152 cases); the typical one trailed it by 3.4%.
- Their past buys: only 1 of 4 beat the S&P 500.
What happened after this filing
7 days
Pending
due Nov 5
30 days
Pending
due Nov 28
90 days
Pending
due Jan 27
Insider Twins: past buys with the same traits
2 insiders buying · no CEO or CFO · $250K–$1M · stock down 0–20% in 3 months
FSTR May 19, 2023 +41.9% vs S&PCLF Dec 13, 2021 +38.1% vs S&PKMPR Aug 8, 2022 +35.3% vs S&PSFST Feb 7, 2023 -46.8% vs S&PSER Aug 22, 2024 -41.9% vs S&PINAB Dec 13, 2022 -39.6% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Gary Torgow (a director) bought $200K of HBAN at about $15.73 on Oct 27, 2026, reported to the SEC on Oct 29, 2026. Buys like this beat the S&P 500 40% of the time since 2020, against 46% for all insider buys. We found 1 point that make it worth a closer look and 4 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the HBAN alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.